Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine response
J. Kovalchin, J. Krieger, M. Genova, K. Collins, M. Augustyniak, A. Masci, T. Hittinger, B. Kuca, Gilles Edan, C. Braudeau, M. Rimbert, U. Patel, E. Mascioli, E. Zanelli